Segal McCambridge Shareholder Walter "Pete" Swayze III To Speak at 2010 Drug Information Association Annual Meeting
Segal McCambridge shareholder Walter "Pete" Swayze III has been asked to speak at the 2010 annual meeting of the Drug Information Association (DIA), to be held June 13 17 at the Walter E. Washington Convention Center in Washington, D.C.
Mr. Swayze, who serves Segal McCambridge as managing shareholder of the firm's Philadelphia office, will take part in a panel titled "Risk Managing Your Clinical Trial Process against Liability Claims," and will address defending and preventing tort liability claims arising from clinical trial adverse events.
The DIA is a professional association of more than 18,000 members worldwide who are involved in discovery, development, regulation, surveillance, or marketing of biopharmaceutical products. To learn more about the organization, click here. To register for the conference, click here.